Literature DB >> 12612937

High frequency of CCR5-delta32 homozygosity in HCV-infected, HIV-1-uninfected hemophiliacs results from resistance to HIV-1.

Mingdong Zhang, James J Goedert, Thomas R O'Brien.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12612937     DOI： 10.1053/gast.2003.50132

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  10 in total

1.  CCR1 and CCR5 promote hepatic fibrosis in mice.

Authors:  Ekihiro Seki; Samuele De Minicis; Geum-Youn Gwak; Johannes Kluwe; Sayaka Inokuchi; Christina A Bursill; Josep M Llovet; David A Brenner; Robert F Schwabe
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

2.  CC chemokine receptor 5 delta32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophilia.

Authors:  Hermann E Wasmuth; Alexa Werth; Tobias Mueller; Thomas Berg; Christoph G Dietrich; Andreas Geier; Ramin Schirin-Sokhan; Carsten Gartung; Johann Lorenzen; Siegfried Matern; Frank Lammert
Journal:  J Mol Med (Berl)       Date:  2003-12-13       Impact factor: 4.599

3.  A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A.

Authors:  Jérôme Lane; Paul J McLaren; Lucy Dorrell; Kevin V Shianna; Amanda Stemke; Kimberly Pelak; Stephen Moore; Johannes Oldenburg; Maria Teresa Alvarez-Roman; Anne Angelillo-Scherrer; Francoise Boehlen; Paula H B Bolton-Maggs; Brigit Brand; Deborah Brown; Elaine Chiang; Ana Rosa Cid-Haro; Bonaventura Clotet; Peter Collins; Sara Colombo; Judith Dalmau; Patrick Fogarty; Paul Giangrande; Alessandro Gringeri; Rathi Iyer; Olga Katsarou; Christine Kempton; Philip Kuriakose; Judith Lin; Mike Makris; Marilyn Manco-Johnson; Dimitrios A Tsakiris; Javier Martinez-Picado; Evelien Mauser-Bunschoten; Anne Neff; Shinichi Oka; Lara Oyesiku; Rafael Parra; Kristiina Peter-Salonen; Jerry Powell; Michael Recht; Amy Shapiro; Kimo Stine; Katherine Talks; Amalio Telenti; Jonathan Wilde; Thynn Thynn Yee; Steven M Wolinsky; Jeremy Martinson; Shehnaz K Hussain; Jay H Bream; Lisa P Jacobson; Mary Carrington; James J Goedert; Barton F Haynes; Andrew J McMichael; David B Goldstein; Jacques Fellay
Journal:  Hum Mol Genet       Date:  2013-01-30       Impact factor: 6.150

4.  CCL3L1 copy number is a strong genetic determinant of HIV seropositivity in Caucasian intravenous drug users.

Authors:  Kristi Huik; Maarja Sadam; Tõnis Karki; Radko Avi; Tõnu Krispin; Piret Paap; Kristi Rüütel; Anneli Uusküla; Ave Talu; Katri Abel-Ollo; Irja Lutsar
Journal:  J Infect Dis       Date:  2010-03       Impact factor: 5.226

Review 5.  Challenges in the management of HIV and hepatitis C virus co-infection.

Authors:  Winston Lee; Douglas Dieterich
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  CCR5 deficiency drives enhanced natural killer cell trafficking to and activation within the liver in murine T cell-mediated hepatitis.

Authors:  Maureen N Ajuebor; Zenebech Wondimu; Cory M Hogaboam; Tai Le; Amanda E I Proudfoot; Mark G Swain
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

Review 7.  Host genetics and HIV-1: the final phase?

Authors:  Jacques Fellay; Kevin V Shianna; Amalio Telenti; David B Goldstein
Journal:  PLoS Pathog       Date:  2010-10-14       Impact factor: 6.823

Review 8.  Clinical implications of chemokines in acute and chronic hepatitis C virus infection.

Authors:  Wonseok Kang; Eui-Cheol Shin
Journal:  Yonsei Med J       Date:  2011-11       Impact factor: 2.759

Review 9.  Beyond HIV infection: Neglected and varied impacts of CCR5 and CCR5Δ32 on viral diseases.

Authors:  Joel Henrique Ellwanger; Bruna Kulmann-Leal; Valéria de Lima Kaminski; Andressa Gonçalves Rodrigues; Marcelo Alves de Souza Bragatte; José Artur Bogo Chies
Journal:  Virus Res       Date:  2020-05-30       Impact factor: 3.303

10.  CCR5 haplotypes influence HCV serostatus in Caucasian intravenous drug users.

Authors:  Kristi Huik; Radko Avi; Andrew Carrillo; Nathan Harper; Merit Pauskar; Maarja Sadam; Tõnis Karki; Tõnu Krispin; Ulvi-Kaire Kongo; Tatiana Jermilova; Kristi Rüütel; Ave Talu; Katri Abel-Ollo; Anneli Uusküla; Sunil K Ahuja; Weijing He; Irja Lutsar
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.